Improved visibility of brain tumors in synthetic MP‐RAGE anatomies with pure T1 weighting
暂无分享,去创建一个
Ralf Deichmann | Elke Hattingen | Ulrike Nöth | R. Deichmann | U. Nöth | E. Hattingen | J. Tichy | O. Bähr | Oliver Bähr | Julia Tichy
[1] P P Fatouros,et al. In Vivo Brain Water Determination by T1 Measurements: Effect of Total Water Content, Hydration Fraction, and Field Strength , 1991, Magnetic resonance in medicine.
[2] Albert Lai,et al. Time course of imaging changes of GBM during extended bevacizumab treatment , 2008, Journal of Neuro-Oncology.
[3] Ralf Deichmann,et al. Within‐lesion differences in quantitative MRI parameters predict contrast enhancement in multiple sclerosis , 2013, Journal of magnetic resonance imaging : JMRI.
[4] Alina Jurcoane,et al. Quantitative T2 mapping of recurrent glioblastoma under bevacizumab improves monitoring for non-enhancing tumor progression and predicts overall survival. , 2013, Neuro-oncology.
[5] Christine Preibisch,et al. MR-based hypoxia measures in human glioma , 2013, Journal of Neuro-Oncology.
[6] J. Smirniotopoulos,et al. Glioblastoma multiforme: radiologic-pathologic correlation. , 1996, Radiographics : a review publication of the Radiological Society of North America, Inc.
[7] J. Mugler,et al. Three‐dimensional magnetization‐prepared rapid gradient‐echo imaging (3D MP RAGE) , 1990, Magnetic resonance in medicine.
[8] M Hoehn-Berlage,et al. Quantitative magnetic resonance imaging of rat brain tumors: in vivo NMR relaxometry for the discrimination of normal and pathological tissues. , 1994, Technology and health care : official journal of the European Society for Engineering and Medicine.
[9] R Deichmann,et al. Quantification of T1 values by SNAPSHOT-FLASH NMR imaging , 1992 .
[10] N. Sakai,et al. Correlation between magnetic resonance imaging and histopathology of intracranial glioma. , 1991, Neurological research.
[11] Terry M Peters,et al. Synthetic T1-weighted brain image generation with incorporated coil intensity correction using DESPOT1. , 2006, Magnetic resonance imaging.
[12] Steen Moeller,et al. T 1 weighted brain images at 7 Tesla unbiased for Proton Density, T 2 ⁎ contrast and RF coil receive B 1 sensitivity with simultaneous vessel visualization , 2009, NeuroImage.
[13] R. Deichmann,et al. Influence of RF spoiling on the stability and accuracy of T1 mapping based on spoiled FLASH with varying flip angles , 2009, Magnetic resonance in medicine.
[14] R Turner,et al. Optimisation of the 3D MDEFT sequence for anatomical brain imaging: technical implications at 1.5 and 3 T , 2004, NeuroImage.
[15] R. Kurland,et al. Magnetic resonance of brain tumors: considerations of imaging contrast on the basis of relaxation measurements. , 1985, Magnetic resonance imaging.
[16] N Jon Shah,et al. MP‐SAGE: A new MP‐RAGE sequence with enhanced SNR and CNR for brain imaging utilizing square‐spiral phase encoding and variable flip angles , 2006, Magnetic resonance in medicine.
[17] D. Louis Collins,et al. Sensitivity of voxel-based morphometry analysis to choice of imaging protocol at 3 T , 2009, NeuroImage.
[18] B A Kall,et al. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. , 1987, Journal of neurosurgery.
[19] Albert Lai,et al. Quantification of edema reduction using differential quantitative T2 (DQT2) relaxometry mapping in recurrent glioblastoma treated with bevacizumab , 2011, Journal of Neuro-Oncology.
[20] E. Hattingen,et al. Bevacizumab impairs oxidative energy metabolism and shows antitumoral effects in recurrent glioblastomas: a 31P/1H MRSI and quantitative magnetic resonance imaging study. , 2011, Neuro-oncology.
[21] Tumours of the Central Nervous System , 1975 .
[22] Ralf Deichmann,et al. A fast B1-mapping method for the correction and normalization of magnetization transfer ratio maps at 3 T , 2010, NeuroImage.
[23] A. Marmarou,et al. Use of magnetic resonance imaging for in vivo measurements of water content in human brain: method and normal values. , 1999, Journal of neurosurgery.
[24] Ralf Deichmann,et al. Quantitative proton density mapping: correcting the receiver sensitivity bias via pseudo proton densities , 2012, NeuroImage.
[25] M. Tovi,et al. MR imaging in cerebral gliomas analysis of tumour tissue components. , 1993, Acta radiologica. Supplementum.
[26] J N Lee,et al. Improved precision in calculated T1 MR images using multiple spin-echo acquisition. , 1986, Journal of computer assisted tomography.
[27] Benjamin M Ellingson,et al. Recurrent glioblastoma treated with bevacizumab: contrast-enhanced T1-weighted subtraction maps improve tumor delineation and aid prediction of survival in a multicenter clinical trial. , 2014, Radiology.
[28] M. Westphal,et al. Signal intensity in T2’ magnetic resonance imaging is related to brain glioma grade , 2011, European Radiology.
[29] Reto Meuli,et al. MP2RAGE Multiple Sclerosis Magnetic Resonance Imaging at 3 T , 2012, Investigative radiology.
[30] R. Deichmann,et al. T1 mapping using spoiled FLASH‐EPI hybrid sequences and varying flip angles , 2009, Magnetic resonance in medicine.
[31] E M Haacke,et al. Accurate determination of spin‐density and T1 in the presence of RF‐field inhomogeneities and flip‐angle miscalibration , 1998, Magnetic resonance in medicine.
[32] J Debus,et al. Fast fluid‐attenuated inversion‐recovery (FLAIR) MRI in the assessment of intraaxial brain tumors , 1998, Journal of magnetic resonance imaging : JMRI.
[33] R. Tanaka,et al. Magnetic resonance imaging and histopathology of cerebral gliomas , 2004, Neuroradiology.
[34] Nikolaus Weiskopf,et al. Unified segmentation based correction of R1 brain maps for RF transmit field inhomogeneities (UNICORT) , 2011, NeuroImage.
[35] Joseph V. Hajnal,et al. High Signal Regions in Normal White Matter Shown by Heavily T2‐Weighted CSF Nulled IR Sequences , 1992, Journal of computer assisted tomography.
[36] Tobias Kober,et al. MP2RAGE, a self bias-field corrected sequence for improved segmentation and T1-mapping at high field , 2010, NeuroImage.
[37] W. Nitz,et al. MP RAGE: a three-dimensional, T1-weighted, gradient-echo sequence--initial experience in the brain. , 1992, Radiology.
[38] R. Turner,et al. Optimization of 3-D MP-RAGE Sequences for Structural Brain Imaging , 2000, NeuroImage.
[39] M. Thelen,et al. Tissue characterization with T1, T2, and proton density values: results in 160 patients with brain tumors. , 1988, Radiology.
[40] Nadim Joni Shah,et al. A new method for fast quantitative mapping of absolute water content in vivo , 2006, NeuroImage.
[41] R. Deichmann,et al. Correction of systematic errors in quantitative proton density mapping , 2012, Magnetic resonance in medicine.